(Q43943693)

28 November 2017

Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease (English)

1 reference

28 November 2017

James J Crute

1

1 reference

28 November 2017

Christine A Grygon

2

1 reference

28 November 2017

Karl D Hargrave

3

1 reference

28 November 2017

Bruno Simoneau

4

1 reference

28 November 2017

Anne-Marie Faucher

5

1 reference

28 November 2017

Gordon Bolger

6

1 reference

28 November 2017

Philip Kibler

7

1 reference

28 November 2017

Michel Liuzzi

8

1 reference

28 November 2017

Michael G Cordingley

9

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

8

1 reference

28 November 2017

386-391

1 reference

28 November 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0402-386

28 November 2017

0 references

cites work

Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

Antiviral resistance in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

Replication of herpes simplex virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

The structure and function of the HSV DNA replication proteins: defining novel antiviral targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

Acyclovir treatment of experimental genital herpes simplex virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

Treatment of recurrent herpes simplex labialis with oral acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

Resistance of herpesviruses to antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

Identification of the primase active site of the herpes simplex virus type 1 helicase-primase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

A DNA helicase induced by herpes simplex virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

An improved assay for nanomole amounts of inorganic phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

Sequence-dependent primer synthesis by the herpes simplex virus helicase-primase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

Parallel-compound synthesis: methodology for accelerating drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

inferred from DOI database lookup

7 January 2021

based on heuristic

Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

inferred from DOI database lookup

7 January 2021

based on heuristic

Cutaneously applied acyclovir acts systemically in the treatment of herpetic infection in the hairless mouse

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-386

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM0402-386

1 reference

28 November 2017

1 reference